Results

Total Results: 1,549 records

Showing results for "drugs".

  1. digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/weingart-sn-et-al-2003
    January 01, 2003 - Weingart SN et al. 2003 "Physicians' decisions to override computerized drug alerts in primary care." Reference Weingart SN, Toth M, Sands DZ, et al. Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med 2003;163(21):2625-2631. [Link] Abstract "Backgroun…
  2. digital.ahrq.gov/sites/default/files/docs/activity/surveillance_for_adverse_drug_events_in_ambulatory_pediatrics_2010pdf_2.pdf
    August 01, 2010 - Surveillance for Adverse Drug Events in Ambulatory Pediatrics 1 | Surveillance for adverSe drug eventS in ambulatory PediatricS 2010 Grant Summary Surveillance for Adverse Drug Events in Ambulatory Pediatrics Principal Investigator: Bailey, Thomas, M.D. Organization: Washington University in St. Louis Mechan…
  3. digital.ahrq.gov/sites/default/files/docs/page/CORLEY_AHRQ_CDSC_5-29.pdf
    April 20, 2013 - uses RxNorm for allergies • First Data Bank does not provide RxNorm mapping for allergies, only drugs
  4. digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/magnus-d-et-al-2002-gps
    January 01, 2002 - Magnus D et al. 2002 "GPs' views on computerized drug interaction alerts: questionnaire survey." Reference Magnus D, Rodgers S, Avery AJ. GPs' views on computerized drug interaction alerts: questionnaire survey. J Clin Pharm Ther 2002;27(5):377-382. Abstract "Background: There is evidence that…
  5. digital.ahrq.gov/ahrq-funded-projects/surveillance-adverse-drug-events-ambulatory-pediatrics
    January 01, 2023 - Surveillance for Adverse Drug Events in Ambulatory Pediatrics Project Final Report ( PDF , 941.73 KB) Disclaimer Disclaimer The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily represent the views …
  6. digital.ahrq.gov/ahrq-funded-projects/prescription-drug-monitoring-program-integration-electronic-health-record
    March 31, 2024 - Prescription Drug Monitoring Program Integration in the Electronic Health Record Project Final Report ( PDF , 415.31 KB) Disclaimer Disclaimer The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily rep…
  7. digital.ahrq.gov/ahrq-funded-projects/meaningful-drug-interaction-alerts/citation/disproportionality
    January 01, 2023 - A disproportionality analysis of drug-drug interactions of tizanidine and CYP1A2 inhibitors from the FDA Adverse Event Reporting System (FAERS). Citation Villa-Zapata L, Gómez-Lumbreras A, Horn J, Tan MS, Boyce RD, Malone DC. A disproportionality analysis of drug-drug interactions of tizanidine and CY…
  8. digital.ahrq.gov/sites/default/files/docs/citation/r01hs025375-zhou-final-report-2022.pdf
    January 01, 2022 - We also created a hierarchy of causative drugs based on a commercial knowledge base (i.e., First DataBank … We first classified drugs into corresponding drug classes using the American Hospital Formulary Service … Finally, our cross- reactivity logic was based on drug classes, not individual drugs. … Although data exist regarding cross-reactivity of individual drugs, it remains an area of uncertainty … penicillins (14%), opioids (10%), sulfonamide antibiotics (9%) and non-steroidal anti-inflammatory drugs
  9. digital.ahrq.gov/sites/default/files/docs/medication-management-elderly-slides-081811.pdf
    August 18, 2011 - Drug-drug interactions: – interaction alerts were beneficial to patient safety – Highly regarded for drugs
  10. digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics-16
    January 01, 2023 - Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records. Citation Phansalkar S, van der Sijs H, Tucker AD, et al. Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records. J Am Med …
  11. digital.ahrq.gov/ahrq-funded-projects/health-information-technology-and-improving-medication-use/citation/reduced
    January 01, 2023 - Reduced effectiveness of interruptive drug-drug interaction alerts after conversion to a commercial electronic health record. Citation Wright A, Aaron S, Seger DL, et al. Reduced effectiveness of interruptive drug-drug interaction alerts after conversion to a commercial electronic health record. J Gen…
  12. digital.ahrq.gov/ahrq-funded-projects/preventing-wrong-drug-and-wrong-patient-errors-indication-alerts-cpoe-systems
    January 01, 2023 - Preventing Wrong-Drug and Wrong-Patient Errors With Indication Alerts in CPOE Systems Project Final Report ( PDF , 953.21 KB) Disclaimer Disclaimer The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessaril…
  13. digital.ahrq.gov/principal-investigator/ferranti-jeffrey
    January 01, 2023 - Ferranti, Jeffrey Sharing adverse drug event data using business intelligence technology. Citation Horvath MM, Cozart H, Ahmad A, et al. Sharing adverse drug event data using business intelligence technology. J Patient Saf 2009 Mar;5(1):35-41. Principal Investigator …
  14. digital.ahrq.gov/2020-year-review/research-summary/anesthesiology-control-tower-air-traffic-control-operating-rooms
    January 01, 2020 - collected during surgery—vital signs, heart rate, blood pressure, temperature, fluid administered, drugs
  15. digital.ahrq.gov/principal-investigator/ratwani-raj-m
    January 01, 2023 - Drugs & Therapy Perspectives; Auckland Vol. 38, Iss. 3, (Mar 2022): 146-155.
  16. digital.ahrq.gov/ahrq-funded-projects/demonstration-project-assessing-significance-and-impact-utilizing-novel
    January 01, 2023 - illness, the natural aging process, and multiple-drug treatment—affect their ability to metabolize drugs
  17. digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/hunt-dl-et-al-1998
    January 01, 1998 - Functions were varied but included drug dosing - particularly for intravenous drugs, patient diagnosis
  18. digital.ahrq.gov/sites/default/files/docs/page/e_prescribing_in_medicaid_chip_agencies__implementation_approaches__challenges__and_opportunities_summary_5.pdf
    October 01, 2009 - if 70% of prescriptions for Medicaid patients are electronically prescribed (excluding scheduled drugs … • Better Visibility—The physician can see interactions for all drugs the patient is using regardless
  19. digital.ahrq.gov/sites/default/files/docs/publication/p20hs015325-hartzema-final-report-2005.pdf
    January 01, 2005 - Automated dispensing cabinets are machines that allow drugs to be dispensed at the point of care, and … Another positive aspect of automated dispensing cabinets is the limited access to drugs in general and … to narcotic drugs in particular. … A5: can configure dispensing only to release pharmacist approved drugs, or can allow certain staff to … Accreditation and Other Considerations n 24hr/7day concurrent Rx review n Controlled access to pharmaceuticals
  20. digital.ahrq.gov/principal-investigator/bailey-thomas
    January 01, 2023 - Bailey, Thomas Natural language processing to identify adverse drug events. Citation Gysbers M, Reichley R, Kilbridge PM, et al. Natural language processing to identify adverse drug events. AMIA Annu Symp Proc 2008 Nov 6:961. Principal Investigator Bailey, Thomas …

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: